A number of other analysts have also commented on BAYN. Jefferies Group LLC set a €125.00 ($138.89) price target on shares of Bayer AG and gave the company a buy rating in a research note on Friday, January 20th. Goldman Sachs Group, Inc. (The) set a €120.00 ($133.33) target price on shares of Bayer AG and gave the stock a buy rating in a research note on Tuesday, January 24th. Sanford C. Bernstein set a €120.00 ($133.33) target price on shares of Bayer AG and gave the stock a buy rating in a research note on Thursday, January 26th. Berenberg Bank set a €118.00 ($131.11) target price on shares of Bayer AG and gave the stock a buy rating in a research note on Friday, January 27th. Finally, Deutsche Bank AG set a €120.00 ($133.33) price target on shares of Bayer AG and gave the stock a buy rating in a report on Tuesday, January 31st. Eight investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average target price of €119.19 ($132.43).
Shares of Bayer AG (FRA BAYN) traded up 0.51% on Friday, reaching €123.31. 4,818 shares of the company traded hands. Bayer AG has a 52-week low of €85.00 and a 52-week high of €123.82. The stock has a 50 day moving average of €117.43 and a 200 day moving average of €106.82. The stock has a market cap of €107.45 billion and a price-to-earnings ratio of 20.40.
TRADEMARK VIOLATION NOTICE: “DZ Bank AG Reiterates “Neutral” Rating for Bayer AG (BAYN)” was reported by BBNS and is the sole property of of BBNS. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://baseballnewssource.com/markets/bayer-ag-bayn-stock-rating-reaffirmed-by-dz-bank-ag-updated-updated-updated/804158.html.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with our FREE daily email newsletter.